RXST RxSight, Inc.

NASDAQ

$4.66

RxSight, Inc. (RXST) is expected to report earnings on November 9, 2026, after the market close. The consensus earnings estimate is a loss of $0.42 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -22.3% since its last earnings release on August 5, 2026.

RxSight Beat Consensus Estimates

Wednesday, August 5, 2026 · 4:05 PM ET

3rd Quarter, Sep 2026

Monday · 4:05 PM ET

Earnings Whisper

-

vs ($0.42)

Rev est $27.49M

Volatility

Enter your expectations below to reveal the current volatility.

Trend Analysis

Expectation

Earnings

Price action

Signals

Score

Sentiment

Grade

Life Cycle

Call Analysis

Earnings-AVWAP $6.29

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About RxSight, Inc.

RxSight, Inc. is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery.

Sector

Healthcare

Industry

Medical Instruments/Supply

Held By 2 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.